229 related articles for article (PubMed ID: 10617927)
1. Role of ICAM-1 (CD54) in the development of murine cerebral malaria.
Favre N; Da Laperousaz C; Ryffel B; Weiss NA; Imhof BA; Rudin W; Lucas R; Piguet PF
Microbes Infect; 1999 Oct; 1(12):961-8. PubMed ID: 10617927
[TBL] [Abstract][Full Text] [Related]
2. Role of CD40-CVD40L in mouse severe malaria.
Piguet PF; Kan CD; Vesin C; Rochat A; Donati Y; Barazzone C
Am J Pathol; 2001 Aug; 159(2):733-42. PubMed ID: 11485931
[TBL] [Abstract][Full Text] [Related]
3. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria.
Lucas R; Juillard P; Decoster E; Redard M; Burger D; Donati Y; Giroud C; Monso-Hinard C; De Kesel T; Buurman WA; Moore MW; Dayer JM; Fiers W; Bluethmann H; Grau GE
Eur J Immunol; 1997 Jul; 27(7):1719-25. PubMed ID: 9247583
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response.
Rudin W; Eugster HP; Bordmann G; Bonato J; Müller M; Yamage M; Ryffel B
Am J Pathol; 1997 Jan; 150(1):257-66. PubMed ID: 9006341
[TBL] [Abstract][Full Text] [Related]
5. Beta interferon suppresses the development of experimental cerebral malaria.
Morrell CN; Srivastava K; Swaim A; Lee MT; Chen J; Nagineni C; Hooks JJ; Detrick B
Infect Immun; 2011 Apr; 79(4):1750-8. PubMed ID: 21245265
[TBL] [Abstract][Full Text] [Related]
6. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.
Amani V; Vigário AM; Belnoue E; Marussig M; Fonseca L; Mazier D; Rénia L
Eur J Immunol; 2000 Jun; 30(6):1646-55. PubMed ID: 10898501
[TBL] [Abstract][Full Text] [Related]
7. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.
Shear HL; Marino MW; Wanidworanun C; Berman JW; Nagel RL
Am J Trop Med Hyg; 1998 Dec; 59(6):852-8. PubMed ID: 9886187
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma is essential for the development of cerebral malaria.
Rudin W; Favre N; Bordmann G; Ryffel B
Eur J Immunol; 1997 Apr; 27(4):810-5. PubMed ID: 9130629
[TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain.
Li J; Chang WL; Sun G; Chen HL; Specian RD; Berney SM; Kimpel D; Granger DN; van der Heyde HC
J Investig Med; 2003 May; 51(3):128-40. PubMed ID: 12769195
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature.
Hearn J; Rayment N; Landon DN; Katz DR; de Souza JB
Infect Immun; 2000 Sep; 68(9):5364-76. PubMed ID: 10948166
[TBL] [Abstract][Full Text] [Related]
11. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria.
Engwerda CR; Mynott TL; Sawhney S; De Souza JB; Bickle QD; Kaye PM
J Exp Med; 2002 May; 195(10):1371-7. PubMed ID: 12021316
[TBL] [Abstract][Full Text] [Related]
12. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.
Piguet PF; Da Laperrousaz C; Vesin C; Tacchini-Cottier F; Senaldi G; Grau GE
Infect Immun; 2000 Jul; 68(7):3822-9. PubMed ID: 10858190
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria.
Claser C; Malleret B; Gun SY; Wong AY; Chang ZW; Teo P; See PC; Howland SW; Ginhoux F; Rénia L
PLoS One; 2011 Apr; 6(4):e18720. PubMed ID: 21494565
[TBL] [Abstract][Full Text] [Related]
14. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria.
Willimann K; Matile H; Weiss NA; Imhof BA
J Exp Med; 1995 Sep; 182(3):643-53. PubMed ID: 7650476
[TBL] [Abstract][Full Text] [Related]
15. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
16. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
17. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
Zanini GM; Cabrales P; Barkho W; Frangos JA; Carvalho LJ
J Neuroinflammation; 2011 Jun; 8():66. PubMed ID: 21649904
[TBL] [Abstract][Full Text] [Related]
18. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
Vigário AM; Belnoue E; Grüner AC; Mauduit M; Kayibanda M; Deschemin JC; Marussig M; Snounou G; Mazier D; Gresser I; Rénia L
J Immunol; 2007 May; 178(10):6416-25. PubMed ID: 17475871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
